Suppr超能文献

老年女性的乳腺癌与骨量:骨密度预筛查对乳腺钼靶检查有用吗?

Breast cancer and bone mass in older women: is bone density prescreening for mammography useful?

作者信息

Kritz-Silverstein D, Schneider D L, Sandwell J

机构信息

Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Drive, 0631-C, La Jolla, 92093-0631, USA.

出版信息

Osteoporos Int. 2006;17(8):1196-201. doi: 10.1007/s00198-006-0124-z. Epub 2006 May 13.

Abstract

INTRODUCTION

The utility of screening mammography for older women with low bone mineral density (BMD) is controversial. This case-control study compares BMD at multiple sites in women with and without breast cancer to determine if BMD prescreening is useful in selecting women for continued screening mammograms.

METHODS

Women diagnosed with breast cancer in the preceding 4 months and age-matched controls (+/-2 years) with a normal mammogram, all aged 65 years and older, were recruited on a 1:2 basis; 237 women participated: 79 women (cases) with breast cancer and 158 controls. BMD at the lumbar spine, hip, radius, and whole body was measured with dual x-ray absorptiometry (DXA).

RESULTS

Among women with breast cancer, 17.1% had stage 0, 41.5% stage I, 40.0% stage II, and 1.4% stage III. Women with breast cancer had larger waist circumferences (p=0.002) and waist-hip ratios (p=0.01), and they exercised less (p=0.002) than women of the control group. However, there were no differences between the cases and controls for age, obesity, and reproductive and menopausal history variables, or other covariates (p>0.10). There were no differences in lumbar spine, total hip, femoral neck, midshaft radius, or total body BMD (p>0.10), although the cases had higher BMD at the ultradistal radius than the controls (means: 0.527 vs. 0.516, respectively; p=0.014). There were no differences in breast cancer risk by tertile of BMD or osteoporosis status at the hip or spine.

CONCLUSION

There is little difference in BMD between women with and without breast cancer. BMD is not useful as a prescreening predicator of mammography in older women and using it as such would result in cases of breast cancer being missed.

摘要

引言

对于骨矿物质密度(BMD)低的老年女性,乳腺钼靶筛查的效用存在争议。这项病例对照研究比较了患有和未患有乳腺癌的女性多个部位的骨密度,以确定骨密度预筛查是否有助于选择女性继续进行乳腺钼靶筛查。

方法

招募了在过去4个月内被诊断患有乳腺癌的女性以及年龄匹配的对照者(±2岁),她们均年龄在65岁及以上,乳腺钼靶检查正常,病例与对照的比例为1:2;共有237名女性参与:79名患有乳腺癌的女性(病例组)和158名对照者。采用双能X线吸收法(DXA)测量腰椎、髋部、桡骨和全身的骨密度。

结果

在患有乳腺癌的女性中,0期占17.1%,I期占41.5%,II期占40.0%,III期占1.4%。患有乳腺癌的女性腰围(p = 0.002)和腰臀比(p = 0.01)更大,且比对照组女性锻炼更少(p = 0.002)。然而,病例组和对照组在年龄、肥胖、生殖和绝经史变量或其他协变量方面没有差异(p>0.10)。腰椎、全髋、股骨颈、桡骨中段或全身骨密度没有差异(p>0.10),尽管病例组超远端桡骨的骨密度高于对照组(均值分别为0.527和0.516;p = 0.014)。根据髋部或脊柱骨密度三分位数或骨质疏松状态划分,乳腺癌风险没有差异。

结论

患有和未患有乳腺癌的女性骨密度差异不大。骨密度不能作为老年女性乳腺钼靶预筛查的预测指标,否则会导致漏诊乳腺癌病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验